These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9436885)

  • 1. In vitro antibiotic susceptibilities of ocular isolates in North and South America. In Vitro Antibiotic Testing Group.
    Jensen HG; Felix C
    Cornea; 1998 Jan; 17(1):79-87. PubMed ID: 9436885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vitro fluoroquinolone resistance in ocular bacterial isolates].
    Sun XG; Wang ZQ; Li R; Chen L; Jin XY; Luo SY
    Zhonghua Yan Ke Za Zhi; 2003 Mar; 39(3):163-6. PubMed ID: 12880574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of in vitro susceptibilities of ocular bacterial isolates to gatifloxacin and other topical antibiotics.
    Kaliamurthy J; Nelson Jesudasan CA; Geraldine P; Parmar P; Kalavathy CM; Thomas PA
    Ophthalmic Res; 2005; 37(3):117-22. PubMed ID: 15746568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro susceptibilities to topical antibiotics of bacteria isolated from the surface of clinically symptomatic eyes.
    Egger SF; Ruckhofer J; Alzner E; Hell M; Hitzl W; Huber-Spitzy V; Grabner G
    Ophthalmic Res; 2001; 33(2):117-20. PubMed ID: 11244359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An in vitro comparison of the susceptibilities of bacterial isolates from patients with conjunctivitis and blepharitis to newer and established topical antibiotics.
    Everett SL; Kowalski RP; Karenchak LM; Landsittel D; Day R; Gordon YJ
    Cornea; 1995 Jul; 14(4):382-7. PubMed ID: 7671609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging fluoroquinolone resistance in bacterial keratitis: a 5-year review.
    Goldstein MH; Kowalski RP; Gordon YJ
    Ophthalmology; 1999 Jul; 106(7):1313-8. PubMed ID: 10406613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro antibiotic susceptibility to fluoroquinolones].
    Wong CA; Galvis V; Tello A; Villareal D; Rey JJ
    Arch Soc Esp Oftalmol; 2012 Mar; 87(3):72-8. PubMed ID: 22423655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of newer fluoroquinolones against gram-positive and gram-negative bacteria isolated from ocular infections: an in vitro comparison.
    Duggirala A; Joseph J; Sharma S; Nutheti R; Garg P; Das T
    Indian J Ophthalmol; 2007; 55(1):15-9. PubMed ID: 17189881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antibiotic susceptibility patterns of bacteria isolated from keratitis and intraocular infections at Fundación Oftalmológica de Santander (FOSCAL), Floridablanca, Colombia].
    Galvis V; Tello A; Guerra A; Acuña MF; Villarreal D
    Biomedica; 2014 Apr; 34 Suppl 1():23-33. PubMed ID: 24968033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro susceptibilities of bacterial ocular isolates to fluoroquinolones.
    Graves A; Henry M; O'Brien TP; Hwang DG; Van Buskirk A; Trousdale MD
    Cornea; 2001 Apr; 20(3):301-5. PubMed ID: 11322420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluoroquinolones in the treatment of bacterial keratitis.
    Bower KS; Kowalski RP; Gordon YJ
    Am J Ophthalmol; 1996 Jun; 121(6):712-5. PubMed ID: 8644818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro comparison of combination and monotherapy for the empiric and optimal coverage of bacterial keratitis based on incidence of infection.
    Kowalski RP; Kowalski TA; Shanks RM; Romanowski EG; Karenchak LM; Mah FS
    Cornea; 2013 Jun; 32(6):830-4. PubMed ID: 23132444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. External ocular surface bacterial isolates and their antimicrobial susceptibility patterns among pre-operative cataract patients at Mulago National Hospital in Kampala, Uganda.
    Mshangila B; Paddy M; Kajumbula H; Ateenyi-Agaba C; Kahwa B; Seni J
    BMC Ophthalmol; 2013 Nov; 13():71. PubMed ID: 24238071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones.
    Alexandrakis G; Alfonso EC; Miller D
    Ophthalmology; 2000 Aug; 107(8):1497-502. PubMed ID: 10919897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vitro selection of bacteria resistant to the 4-quinolone agents.
    Limb DI; Dabbs DJ; Spencer RC
    J Antimicrob Chemother; 1987 Jan; 19(1):65-71. PubMed ID: 3470281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacterial spectrum and antimicrobial susceptibility patterns in acquired and connatal lacrimal duct stenosis.
    Prokosch V; Prokosch JE; Promesberger J; Idelevich EA; Böhm MR; Thanos S; Stupp T
    Curr Eye Res; 2014 Nov; 39(11):1069-75. PubMed ID: 24912091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis on susceptibility of ocular bacterial pathogens to four kinds of fluoroquinolone].
    Wang ZQ; Li L; Li R; Luo SY; Bai XQ; Liang QF; Deng SJ; Sun XG
    Zhonghua Yan Ke Za Zhi; 2008 Mar; 44(3):233-6. PubMed ID: 18785547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence of resistance to fluoroquinolones among gram positive and gram negative clinical isolates.
    Nesar S; Shoaib MH; Rahim N; Rehman R
    Pak J Pharm Sci; 2012 Oct; 25(4):877-81. PubMed ID: 23010009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Twelve-year analysis of microbial keratitis trends at a UK tertiary hospital.
    Tan SZ; Walkden A; Au L; Fullwood C; Hamilton A; Qamruddin A; Armstrong M; Brahma AK; Carley F
    Eye (Lond); 2017 Aug; 31(8):1229-1236. PubMed ID: 28452995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogen of occurrence and susceptibility patterns associated with pneumonia in hospitalized patients in North America: results of the SENTRY Antimicrobial Surveillance Study (2000).
    Hoban DJ; Biedenbach DJ; Mutnick AH; Jones RN
    Diagn Microbiol Infect Dis; 2003 Apr; 45(4):279-85. PubMed ID: 12730000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.